Adding tislelizumab to chemo slows advanced nasopharyngeal cancer
23 Apr 2022
Medical Xpress
The addition of tislelizumab to chemotherapy improves progression-free survival (PFS) in recurrent/metastatic nasopharyngeal cancer (RM NPC), according to a study presented April 18 as part of the American Society for Clinical ...